Apotex Seeks Stay In Plavix Suit Pending USPTO Ruling
Apotex Inc. is asking a federal court to stay its long-running patent suit with Sanofi-Aventis SA over the blood-thinning drug Plavix while the U.S. Patent and Trademark Office re-examines Sanofi's patent...To view the full article, register now.
Already a subscriber? Click here to view full article